KFF November 28, 2023
In 2023, the FDA approved the first over-the-counter (OTC) daily oral contraceptive pill, Opill, and more recently, the first OTC at-home test for chlamydia and gonorrhea, Simple 2 Test. With these OTC products becoming available online and/or in stores soon, the implementation issues raised about the availability and affordability of these products and other OTC preventive supplies have garnered the attention of policymakers and advocates. Private insurers and Medicaid generally require a prescription to cover OTC products, so even though these products will be available without the need to obtain a prescription from a clinician, coverage without a prescription will be limited without federal or state action.
In October 2023, the Departments of the Treasury, Labor, and Health and Human...
Today's Sponsors
Today's Sponsor